Pancreatic Cancer Research

ResearcherShizuoka Cancer CenterNo recent work listed

Takaaki Ito

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-8678-2653; OpenAlex author ID A5023519370. Sources: OpenAlex.

Their work

Papers
16
Trials
0
Grants
0
Labs led
0
Collaborators
16
Papers, trials and grants by year

2017: 3 papers · 2018: 1 paper · 2019: 1 paper · 2020: 3 papers · 2021: 7 papers · 2022: 1 paper

Papers 16

  1. The clinical benefits of performing staging laparoscopy for pancreatic cancer treatment. Co-author DOI 10.1016/j.pan.2022.03.017↗
  2. The influence of familial pancreatic cancer on postoperative outcome in pancreatic cancer: relevance to adjuvant chemotherapy. Co-author DOI 10.1007/s00535-020-01730-7↗
  3. The preoperative controlling nutritional status (CONUT) score is an independent prognostic marker for pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s13304-020-00792-9↗
  4. Predictive factors of survival in patients with borderline resectable pancreatic cancer who received neoadjuvant therapy. Co-author DOI 10.1016/j.pan.2021.08.009↗
  5. Reconsidering the Optimal Regional Lymph Node Station According to Tumor Location for Pancreatic Cancer. Co-author DOI 10.1245/s10434-020-09066-5↗
  6. Clinical Implication of Node-negative Resectable Pancreatic Cancer. Co-author DOI 10.1245/s10434-020-09543-x↗
  7. Clinical Significance of Preoperative Albumin-Bilirubin Grade in Pancreatic Cancer. Co-author DOI 10.1245/s10434-021-09593-9↗
  8. ASO Author Reflections: Albumin-Bilirubin Grade is an Independent Prognostic Factor Complementary to CA19-9 for Pancreatic Cancer Patients. Co-author DOI 10.1245/s10434-021-09660-1↗
  9. Oncological benefit of metformin in patients with pancreatic ductal adenocarcinoma and comorbid diabetes mellitus. Co-author DOI 10.1007/s00423-020-01874-3↗
  10. Prognostic impact of abutment to the branches of the superior mesenteric artery in borderline resectable pancreatic cancer. Co-author DOI 10.1007/s00423-020-01970-4↗
  11. Middle segment-preserving pancreatectomy for multifocal pancreatic ductal adenocarcinoma located in the head and tail of the pancreas: a case report. Co-author DOI 10.1093/jscr/rjaa383↗
  12. Prognostic role of the length of tumour-vein contact at the portal-superior mesenteric vein in patients having surgery for pancreatic cancer. Co-author DOI 10.1002/bjs.11328↗
  13. Microscopic Venous Invasion in Pancreatic Cancer. Co-author DOI 10.1245/s10434-017-6324-2↗
  14. Prognostic Scoring System for Patients Who Present with a Gastric Outlet Obstruction Caused by Advanced Pancreatic Adenocarcinoma. Co-author DOI 10.1007/s00268-017-4027-2↗
  15. The diagnostic advantage of EOB-MR imaging over CT in the detection of liver metastasis in patients with potentially resectable pancreatic cancer. Co-author DOI 10.1016/j.pan.2017.03.001↗
  16. Reply to the letter to the editor regarding "The diagnostic advantage of EOB-MR imaging over CT in the detection of liver metastasis in patients with potential… Co-author DOI 10.1016/j.pan.2017.06.012↗

Closest collaborators

The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Teiichi Sugiura · 16 shared papers, 2017–2022 · strength 1.83
  2. Katsuhiko Uesaka · 16 shared papers, 2017–2022 · strength 1.83
  3. Ryo Ashida · 15 shared papers, 2017–2022 · strength 1.74
  4. Yukiyasu Okamura · 15 shared papers, 2017–2022 · strength 1.74
  5. Katsuhisa Ohgi · 12 shared papers, 2019–2022 · strength 1.51
  6. Taisuke Imamura · 6 shared papers, 2019–2022 · strength 0.75
  7. Akira Fukutomi · 3 shared papers, 2019–2021 · strength 0.32
  8. Akiko Todaka · 3 shared papers, 2019–2021 · strength 0.32
  9. Koji Tezuka · 2 shared papers, 2021 · strength 0.26
  10. Fumihiro Terasaki · 2 shared papers, 2020–2021 · strength 0.26
  11. Mihoko Yamada · 2 shared papers, 2018–2021 · strength 0.21
  12. Shunsuke Tamura · 1 shared paper, 2022 · strength 0.15
  13. Yusuke Yamamoto · 1 shared paper, 2021 · strength 0.13
  14. Nobuhito Nitta · 1 shared paper, 2020 · strength 0.11
  15. Masato Nagino · 1 shared paper, 2018 · strength 0.08
  16. Yukio Yoshida · 1 shared paper, 2017 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.